Barrett’s esophagus is characterized by the replacement of stratified squamous epithelium by simple columnar epithelium with goblet cells. It is an ominous sequela of uncontrolled or poorly controlled gastroesophageal reflux disease. As a potential precursor to adenocarcinoma, Barrett’s esophagus can be devastating if undiagnosed or untreated. The ability to identify at-risk patients is imperative to provide prompt diagnosis. This is then followed by appropriate treatment dictated by the presence and degree of dysplasia. After therapy, endoscopic surveillance is vital to the lifelong care of patients with Barrett’s esophagus.
KeywordsBarrett’s esophagus Barrett’s esophagitis Barrett’s syndrome Gastroesophageal reflux disease Endoscopic eradication therapy Antireflux surgery
- 2.Freedberg DE, Kim LS, Yang Y-X. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology [Internet]. 2017;152(4):706–15. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0016508517300914.CrossRefGoogle Scholar